1. Home
  2. MIND vs LUNG Comparison

MIND vs LUNG Comparison

Compare MIND & LUNG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MIND Technology Inc. (DE)

MIND

MIND Technology Inc. (DE)

N/A

Current Price

$8.10

Market Cap

83.4M

Sector

Industrials

ML Signal

N/A

Logo Pulmonx Corporation

LUNG

Pulmonx Corporation

N/A

Current Price

$1.78

Market Cap

72.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MIND
LUNG
Founded
1987
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Industrial Specialties
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
83.4M
72.2M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
MIND
LUNG
Price
$8.10
$1.78
Analyst Decision
Buy
Analyst Count
0
7
Target Price
N/A
$5.38
AVG Volume (30 Days)
102.0K
645.4K
Earning Date
01-01-0001
06-01-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
10.00
EPS
N/A
N/A
Revenue
N/A
$83,789,000.00
Revenue This Year
N/A
$6.20
Revenue Next Year
$8.08
$21.61
P/E Ratio
$22.27
N/A
Revenue Growth
N/A
22.01
52 Week Low
$4.45
$1.31
52 Week High
$14.50
$8.10

Technical Indicators

Market Signals
Indicator
MIND
LUNG
Relative Strength Index (RSI) 47.59 55.32
Support Level $7.91 $1.44
Resistance Level $9.27 $1.93
Average True Range (ATR) 0.46 0.16
MACD 0.05 0.05
Stochastic Oscillator 55.15 48.67

Price Performance

Historical Comparison
MIND
LUNG

About MIND MIND Technology Inc. (DE)

MIND Technology Inc provides technology and solutions for exploration, survey, and defense applications in oceanographic, hydrographic, defense, seismic, and security industries. The company operates in segments namely, Seamap Marine Products and Klein Marine Products helps manufacture and sell specialized, high-performance sonar and seismic equipment. The company generates more revenue from Seamap Marine Products. The company's geographical segments include the United States; China, Norway; Turkey; Singapore; and Canada & Other.

About LUNG Pulmonx Corporation

Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.

Share on Social Networks: